Brazil IP counsel for foreign law firms, agents and in-house teams.

Brazil IP counsel for foreign law firms, agents and in-house teams. https://validator.w3.org/feed/docs/rss2.html TWS AI-Powered IP Tool – Português Brazil’s “Lei Felca” Enters into Force Today: Why Children’s Data, AI, and Digital Products Are the Next Enforcement Frontier Brazilian IP News New DIRPA Rule on Patent Technical Examination: Why It Matters in Practice in Brazil Nova Portaria da DIRPA sobre Exame Técnico de Patentes: o que ela revela sobre a lógica atual do exame no Brasil Brazil Establishes a Fully Regulated Cannabis Medicinal Framework — Strategic Implications for IP, Compliance and Market Entry About US Brazil’s Innovation System: Institutions, Policy Instruments, and Strategic Opportunities for Global Technology Partnerships Historic milestone: Brazil and the European Union achieve mutual adequacy in data protection What the Ozempic® and Rybelsus® decision really means for pharma strategy in 2026 New agency AI tool cuts classification prep from 5 months to 5 minutes. How “Class ACT” Helps the USPTO Handle Figurative Marks Faster When Breakthrough Science Meets Fragile Global IP Brazil Pharma IP Threat Board 2026 Brazil’s Health Authority Publishes Guidance on Monitoring International Health Regulation (IHR) Core Capacities at Designated Points of Entry Brazil’s Data Protection Authority Sets the Regulatory Agenda for 2026–202 brazil-ip-compliance-intelligence AI + IP Strategy Outlook 2026 – Brazil IP Risk Snapshot LATAM IP Market Entry Intelligence (Powered by RPI Data) Welcome Cookie Policy Brazil & LATAM IP Risk Intelligence for Foreign IP Law Firms Purchasing Options CHINA access SINGAPORE Artificial Intelligence in the Brazilian Justice System our-mission Brazil IP Law & AI – MJZanon Examination Framework for Trademarks: What Global IP Owners Need to Know in 2025 Brazil’s 2025 Trademark Reform Our IP Services Rare Minerals: Brazil’s Strategic Leap into the Clean-Energy Geopolitics SICX & The Acceleration Act – MJZanon Insights Augmenting the IP Examiner: How AI Is Transforming Patent, Trademark and Design Examination EUA Propoem Restrições ao IPR: Revisão Inter Partes de Patentes (Validade 20 anos) sob Nova Ameaça Regulatória Brazil’s INPI Launches New Pricing Policy: A Strategic Shift Toward Inclusive, Transparent, and Innovation-Driven IP Services JAPAN Examinador-IA × Requerente-IA: como a IA está transformando o exame de Propriedade Intelectual USPTO 2025: “Tríade letal” para desafios de validade? O que a guinada política significa para inovadores, investidores e litigantes U.S. Drug Price Reform Accelerates: Trump Targets Pharma CEOs in Bold MFN Policy Revival USPTO Clarifies §101 Examination for Software, AI & ML: A Playbook for Stronger Claims CAS & CAPES ampliam acesso ao CAS BioFinder™ — avanço estratégico para pesquisa e inteligência de patentes no Brasil INPI Rejects Bradesco’s Nullity Attempts: What the NFTSTAR Case Reveals About IP Strategy Brazil Pharma IP & Business Intelligence Report – RPI 2853 USA Brazil’s INPI Trademark & Patent Fee Changes 2025 – What Clients Need to Know PL 2338/2023 e a Proteção de Dados na Era da IA – Diálogo entre LGPD, GDPR e CPRA welcome The Pharma Market Is Shifting. Are You Monitoring It Weekly